The groundbreaking rise of Viagra has long been a symbol of pharmaceutical success, but its legacy within the broader industry now presents questions about future returns . Copycat versions are eroding market share, leading to worries that betting on companies closely tied to Viagra's previous standing could be a problematic strategy, especially gi